Abstract
Tumors of the head and neck region comprise a heterogeneous group of neoplastic processes. Due to the complicated anatomical situation, head and neck tumors exhibit characteristic epidemiological, pathological and therapeutic features. Despite these differences, there are certain common properties concerning the anatomy of the regional drainage of lymph nodes and lymph vessels of the head and neck, the pathology, staging and screening, as well as pertaining therapeutic approaches. As a result, the head and neck have been subdivided into the following regions: nasal cavity, paranasal sinus, nasopharynx, oral cavity, oropharynx, hypopharynx and larynx.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams S, Baum RP, Stuckensen T, et al. (1998) Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260
Assar OS, Fischbein NJ, Caputo GR, et al. (1999) Metastastatic head and neck cancer: role and usefullness of FDG-PET in locating occult primary tumors. Radiology 210:177–181
Bailet JW, Abemayor E, Jabour BA, et al. (1992) Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope. 102: 281–288
Bender H, Straehler-Pohl HJ, Schomburg A, et al. (1997) Value of F-18-DG-PET in the assessment of head and neck tumors. J Nucl Med 38:153 (abstr)
Bender H, Straehler-Pohl HJ, Frohmann JP et al. (1998) FDG-PET as a clinical routine tool for the staging of selected tumors: results and implications In: Limouris GS, Bender H, Biersack HJ (eds) Radionuclides for therapy. Mediterra Publishers Athens
Bender H, Straehler-Pohl HJ, Linke D, et al. (1998) Klinische Bedeutung von 18FDGPET in der Diagnostik von Kopf-Hals-Tumoren. Nuklearmedizin 37:30 (abstr)
Bender H, Metten N, Bangard N, et al. (1999) Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal carcinoma. Hybridoma 18: 87–91
Braams JW, Pruim J, Freling NJ, et al. (1995) Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36: 211–216
Braams JW, Pruim J, Kole AC, et al. (1997) Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg 26:112–115
Berlangieri SU, Brizel DM, Scher RL, et al. (1994) Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck 16:340–346
Cancer Statistics (1994) Cancer journal for clinicians. American Cancer Society 44:9–26
Donald PJ (1986) Marijuana smoking: possible cause of head and neck carcinoma in young patients. Otolaryngol Head Neck Surg 94:517–519
Fahraeus R, Fu HL, Ernberg I, et al. (1988) Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329–331
German J (1983) Chromosome Mutation and Neoplasia. Alan R Liss, New York
Greven KM, McGuirt WF, Watson X, et al. (1995) PET in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 104:274–278
Greven KM, Williams DW 3rd, Keyes JW Jr et al. (1994) Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74:1355–1359
Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. (1993) Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 34:12–17
Haberkorn U, Strauss LG, Reisser C, van Kaick G, et al. (1992) Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors. Radiologe 32:296–301
Jabour BA, Choi Y, Hoh CK, et al. (1993) Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 186:27–35
Keyes JW, Harkness BA, Greven KM, et al. (1994) Salivary gland tumors: pretherapy evaluation with PET. Radiology 1992:99–102
Kole AC, Nieweg 0E, Pruim J, et al. (1998) Detection of unknown occult primary tumors using positron emission tomography. Cancer 82:1160–1166
Laubenbacher C, Saumweber D, Wagner Manslau C et al. (1995) Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 36:1747–1757
Mancuso AA, Drane WE, Mukherji SK (1994) The promise FDG in diagnosis and surveillance of head and neck cancer. Cancer 74:1193–1195
Mashberg A, Garfinkel L, Harris S (1981) Alcohol as a primry factor in oral squamous carcinoma. CA Cancer J Clin 31:146–148
McGuirt WF, Greven KM, Keyes JW et al. (1995) Positron emission tomography in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 104:274–278
McGuirt WF, Keyes JW, Greven KM et al. (1995) Preoperative identification of benign versus malignant parotid masses: a comparative study including positron emission tomography. Laryngoscope 105:579–584
McGuirt WF, Williams DW 3rd, Keyes JW Jr, et al. (1995) A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 105:373–375
Mendenhall WM, Manusco AA, Parsons JT, et al. (1998) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head-Neck 20:739–744
Minn H, Clavo AC, Grenman R, Wahl RL (1995) In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous cell carcinoma of the head and neck. J Nucl Med 36:252–258
Moser E, Krause T (1997) Konsensus - Onko-PET: Arbeitsausschuß Posit:ronen-Emissions-Tomographie der DGN, Vorsitz Reske SN, 2. Konsensuskonferenz in Ulm. Nudearmedizin 36:45–46
Mukherji SK, Drane WE, Mancuso AA, et al. (1996) Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT. Radiology 199:761–766
Mukherji SK, Drane WE, Tart RP, et al. (1994) Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck. Am J Neuroradiol 15: 1837–1842
Old LJ, Boyse EA, Oettgen, et al. (1966) Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sci USA 56:1699–1701
Rege S, Maass A, Chaiken L, et al. (1994) Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73: 3047–3058
Rege SD, Chaiken L, Hoh CK, et al. (1993) Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 189:807–812
Reisser C, Haberkorn U, Strauss LG (1991) PET scan in tumor diagnosis in the head and neck. Laryngorhinootologie 70:214–217
Reisser C, Haberkorn U, Strauss LG (1992) Diagnosis of energy metabolism in ENT tumors - a PET study. HNO 40:225–231
Reisser C, Haberkorn U, Strauss LG (1993) The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 22: 231–238
Schantz SP, Harrison LB, Forastiere AA (1997) Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity and orophrarunx. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer, Principles and Practice of Oncology. Lippincott-Raven Publ New York, pp 741–801
Schantz SP, Hsu TC (1989) Head and neck cancer patients express increased clastogeninduced chromosome fragility. Head Neck 11:337–339
Schipper JH, Schrader M, Arweiler D, et al. (1996) Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor. HNO 44:254–257
Seifert E, Schadel A, Haberkorn U, Strauss LG (1992) Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan). HNO 40:90–93
Shemen LJ, Klotz J, Shottenfeld D, Strong EW (1984) Increase of tongue cancer in young men. JAMA 252:1857–1859
Spitz MR, Fuegger JJ, Goeffert H, et al. (1988) Squamous cell carcinoma of the upper aerodigestive tract: a case comparison analysis. Cancer 61:203–209
Straehler-Pohl HJ, Bender H, Linke D, et al. (1998) Value of F-18-DG-PET in the assessment of head and neck tumors: clinical experience in 152 patients. J Cancer Res Clin Oncol 124:R10
Straehler-Pohl HJ, Bender H, Linke D, et al. (1998) Value of F-18-DG-PET in the staging of head and neck tumors under clinical routine conditions. Eur J Nucl Med 25:1032 (abstr)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bender, H., Straehler-Pohl, H.J. (2000). PET in head and neck tumors. In: Wieler, H.J., Coleman, R.E. (eds) PET in Clinical Oncology. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57703-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-57703-1_13
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63329-4
Online ISBN: 978-3-642-57703-1
eBook Packages: Springer Book Archive